Lamictal is not lithium. They are two different medications that happen to share a role in treating bipolar disorder, which is likely why they get confused. Lamictal is the brand name for lamotrigine, an anticonvulsant originally developed for epilepsy. Lithium is a naturally occurring element (a type of salt) that has been used in psychiatry since the 1940s. They work differently, treat different phases of the illness, and come with very different side effect profiles and monitoring requirements.
What Each Drug Actually Does
Both Lamictal and lithium are classified as mood stabilizers, but they stabilize mood from opposite directions. Lithium is primarily effective against mania. It helps control the elevated, impulsive, high-energy episodes that characterize bipolar I disorder. Think of it as putting a ceiling on mood.
Lamictal works from the other end. Its main strength is preventing depressive episodes. It stabilizes mood from below, helping keep people from sinking into the prolonged lows that are especially common in bipolar II disorder. Neither drug is FDA-approved specifically for treating acute bipolar depression, but Lamictal’s preventive effect against depressive relapse is its primary value in bipolar care.
How They’re Taken Differently
One of the biggest practical differences is how you start each medication. Lamictal requires an unusually slow dose increase over several weeks to reduce the risk of a serious skin reaction (more on that below). A typical starting schedule for someone not on other interacting medications is 25 mg daily for the first two weeks, then 50 mg daily for weeks three and four, then gradual increases from there. Reaching a full therapeutic dose takes at least six weeks.
Lithium doesn’t require the same gradual ramp-up for safety reasons, but it does require something Lamictal doesn’t: regular blood draws. Lithium has a narrow therapeutic window, meaning the difference between an effective dose and a toxic one is relatively small. Blood levels need to stay in a range generally between 0.6 and 1.2 mEq/L. When you first start lithium, blood levels are typically checked twice a week until they stabilize. Even once you’re on a steady dose, periodic blood monitoring continues indefinitely.
Blood draws for lithium need to happen 8 to 12 hours after your last dose to get an accurate reading. Lamictal doesn’t require routine blood level monitoring.
Side Effects and Risks
The side effect profiles are quite different, which often influences which medication a prescriber chooses.
Lithium’s most well-known concerns are kidney function and thyroid function. Long-term use can affect both, which is part of why regular lab work is necessary. It can also cause tremor, increased thirst, frequent urination, and weight gain. Dehydration, certain pain relievers like ibuprofen, and some blood pressure medications can reduce how quickly your body clears lithium, raising the risk of toxicity. Staying well-hydrated and keeping your prescriber informed about any new medications is important.
Lamictal’s signature risk is a potentially serious skin rash. In clinical trials, about 0.3% of adults developed a rash serious enough to require hospitalization, and roughly 0.1% of adults developed what may have been Stevens-Johnson syndrome, a rare but dangerous skin reaction. The risk is higher in children under 16, where serious rash occurred in about 1% of patients. The slow dose escalation exists specifically to minimize this risk. Any new rash that develops while starting Lamictal warrants immediate medical attention. Beyond the rash concern, Lamictal is generally well tolerated. Common side effects include headache, dizziness, and nausea, but it tends to cause less weight gain and cognitive dulling than many other mood stabilizers.
Drug Interactions Worth Knowing
Lamictal has one particularly important interaction: valproic acid (Depakote). Valproate more than doubles the time it takes your body to clear lamotrigine, which can dramatically increase lamotrigine levels and raise the risk of that serious rash. When someone takes both medications together, the lamotrigine dose needs to be cut in half, and the starting schedule is even slower, beginning at 25 mg every other day rather than every day.
Lithium’s major interactions involve anything that changes how your kidneys handle sodium. Diuretics (especially thiazides), ACE inhibitors, and common over-the-counter anti-inflammatory drugs like ibuprofen and naproxen can all cause lithium to build up in your system. Any time one of these medications is started, stopped, or adjusted, lithium levels should be rechecked.
Can You Take Them Together?
Yes, and some people do. Because lithium and Lamictal target different poles of bipolar disorder, combining them is a recognized strategy, particularly for people with rapid cycling bipolar disorder where both manic and depressive episodes occur frequently. A meta-analysis looking at the combination for rapid cycling found the evidence wasn’t strong enough to draw firm conclusions about added benefit, but the combination remains a common clinical approach when a single mood stabilizer isn’t enough.
The two drugs don’t directly interact with each other the way lamotrigine interacts with valproate, so there isn’t a specific dose adjustment needed when combining them. However, thyroid function should be monitored, since both lithium and bipolar disorder itself can affect thyroid levels.
Which One Gets Prescribed When
The choice between these medications often comes down to which part of bipolar disorder causes the most trouble. If manic episodes are the primary concern, lithium is typically the stronger option. If depressive episodes dominate the picture, as they often do in bipolar II, Lamictal tends to be preferred. For bipolar I disorder with both significant manic and depressive episodes, a prescriber might start with lithium and add Lamictal later if depression breaks through.
Practical factors matter too. Someone who can’t reliably get blood work done may not be a good candidate for lithium. Someone who needs rapid symptom control during an acute episode won’t get it from Lamictal, which takes weeks to reach a therapeutic dose. Kidney problems or thyroid disease may steer prescribers away from lithium, while a history of serious drug rashes may make Lamictal a riskier choice.